RV/LV Analysis
Imbio
Information source:
Vendor
Last updated: March 19, 2025 |
General Information
General | |
---|---|
Product name | RV/LV Analysis |
Company | Imbio |
Subspeciality | Cardiac, Chest |
Modality | CT |
Disease targeted | Pulmonary Embolism |
Key-features | Ventricle diameter quantification, RV/LV ratio |
Suggested use | Before: stratifying reading process (non, single, double read), adapting worklist order, flagging acute findings During: perception aid (prompting all abnormalities/results/heatmaps), interactive decision support (shows abnormalities/results only on demand), report suggestion Without interference of a radiologist: AI-only diagnosis |
Technical Specifications
Data characteristics | |
---|---|
Population | |
Input | Contrast CT |
Input format | DICOM |
Output | Quantitative report |
Output format | PDF and DICOM |
Technology | |
Integration | Integration in standard reading environment (PACS), Integration via AI marketplace or distribution platform, Stand-alone third party application, Stand-alone webbased |
Deployment | Locally virtualized (virtual machine, docker), Cloud-based |
Trigger for analysis | Automatically, right after the image acquisition, On demand, triggered by a user through e.g. a button click, image upload, etc. |
Processing time | 1 - 10 minutes |
Regulatory
Certification | |
---|---|
CE |
Certified,
Class IIa
, MDR
|
FDA | 510(k) cleared , Class II |
Intended Use Statements | |
Intended use (according to CE) |
Market
Market presence | |
---|---|
On market since | 03-2021 |
Distribution channels | Blackford |
Countries present (clinical, non-research use) | <5 |
Paying clinical customers (institutes) | N/A |
Research/test users (institutes) | >5 |
Pricing | |
Pricing model | Pay-per-use, Subscription |
Based on | Number of installations, Number of analyses |
Evidence
Evidence | |
---|---|
Peer reviewed papers on performance |
|
Non-peer reviewed papers on performance | |
Other relevant papers |